All In Biotech

Drug Trial Radar · NCT01350063

Health Impact of Treating and Safely Storing Shallow Tubewell Drinking Water

Last checked: Nov 20, 2026Latest source record: Jan 3, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,800 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,800

Actual

Start

Feb 2011

Primary completion

May 2012

Study completion May 2012

Sponsor

Sponsor type
Academic, hospital or other
First posted
May 9, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 6 months, up to 5 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

When shallow tubewells replaced highly contaminated surface water as the primary source of drinking water in Bangladesh in the late 20th century, contemporary studies demonstrated no reduction in diarrheal disease with this improvement in water source. This lack of improvement in transitioning to tubewells is consistent with the lack of significant health gains observed in intervention studies focusing on water quality improvements at the source. In contrast, high quality intervention studies that improve water quality at the point of use through treatment of water in households show a 39% reduction in diarrhea. The primary objective of this study is within a typical setting in rural Bangladesh where households use shallow tubewell water for drinking. The investigators will randomly assign 1800 households who have a child between the ages of six months and two years to one of three groups. Group 1 will receive a safe water storage vessel with a lid and a narrow mouth/tap and Aquatabs, an effervescent water purification tablet that utilizes sodium dichloroisocyanurate (NaDCC) as the chlorine donor. Group 2 will only receive a safe water storage vessel with a lid and a narrow mouth/tap. Group 3 will receive no water intervention and continue their standard habits and practices. Every month a field research assistant will visit each participating household and collect information on the prevalence of diarrhea among children between the ages of six months and two years, as well as children between the ages of two and five years if present in the household. Diarrhea prevalence in the 48 hours and 7 days preceding the visit will be recorded. The investigators will compare the longitudinal prevalence of diarrhea between the following groups: (1) households that receive chlorine and storage container versus households that only receive storage container to assess the effect of chlorination, (2) households that only receive storage container versus households that receive no intervention to assess the effect of safe storage, and (3) households that receive chlorine and storage container versus households that receive no intervention to assess the combined effect of chlorination and safe storage. Hypothesis: Drinking water from shallow tubewells that are intermittently contaminated with enteric pathogens contributes importantly to diarrhea among children in rural Bangladesh.

Conditions

  • Diarrhoeal Disease

Interventions

  • Sodium dichloroisocyanurate (NaDCC) tablet (Aquatab)Drug

    One tablet should be added to 10L container, resulting in a free chlorine dose of 2 mg/L.

  • Water storage container (Jerry can)Device

    Shallow tubewell water should be stored in 10L container.

  • No interventionOther

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Diarrhoeal incidence among children between 6 months to 5 years of age.Time frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Fulbaria sub-district

    Mymensingh, Bangladesh

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.